Mini Quiz: Antipsychotic Metabolic Effects

Poll

Metabolic syndrome may be a particularly important marker of antipsychotic metabolic effects.

Metabolic syndrome may be a particularly important marker of antipsychotic metabolic effects because antipsychotic treatment is associated with all of the following except:

A. Metabolic dyslipidemia (raised triglyceride and low high-density lipoprotein cholesterol levels)
B. Increased blood pressure
C. Abdominal adiposity (increased waist circumference)
D. Dysglycemia (increased glucose)
E. Hyperinsulinemia
Related Videos
Experts on MDD.
Experts on MDD.
Related Content

A Look Back at the 2022 Annual Psychiatric Times® World CME Conference

October 3rd 2023

Here's to a Psychedelic Revolution

April 9th 2022

From the Pages of Psychiatric Times: September 2023

September 30th 2023

Blue Light Blockers: A Behavior Therapy for Mania

October 7th 2021

Psychiatry in the News: September 2023

September 29th 2023

FDA Approves First Oral Selective 5HT1A Receptor Agonist for MDD

September 29th 2023

A Look Back at the 2022 Annual Psychiatric Times® World CME Conference

October 3rd 2023

Here's to a Psychedelic Revolution

April 9th 2022

From the Pages of Psychiatric Times: September 2023

September 30th 2023

Blue Light Blockers: A Behavior Therapy for Mania

October 7th 2021

Psychiatry in the News: September 2023

September 29th 2023

FDA Approves First Oral Selective 5HT1A Receptor Agonist for MDD

September 29th 2023

A Look Back at the 2022 Annual Psychiatric Times® World CME Conference

October 3rd 2023

Here's to a Psychedelic Revolution

April 9th 2022

From the Pages of Psychiatric Times: September 2023

September 30th 2023

Blue Light Blockers: A Behavior Therapy for Mania

October 7th 2021

Psychiatry in the News: September 2023

September 29th 2023

FDA Approves First Oral Selective 5HT1A Receptor Agonist for MDD

September 29th 2023
© 2023 MJH Life Sciences

All rights reserved.